Format

Send to

Choose Destination
Cancer. 1989 Sep 15;64(6):1192-4.

Low-dose chemotherapy of desmoid tumors.

Author information

1
Department of Medicine, Thomas Jefferson School of Medicine, Philadelphia, Pennsylvania.

Abstract

Eight patients with desmoid tumors, symptomatic, and none a candidate for conservative surgery, were treated with weekly vinblastine, maximum dose 10 mg/week, and methotrexate, maximum dose 50 mg/week. Symptomatic relief was obtained in all patients. Using Eastern Cooperative Oncology Group (ECOG) criteria, two patients had a complete remission, one of which has lasted for 30 months, four patients have had partial remissions, one patient has had a mixed response, and one patient who has been treated for only 4 weeks, a minimal response. Toxicity has been minor and transient. Chemotherapy appears to be an acceptable alternative to radical surgery in selected patients with desmoid tumors.

PMID:
2766217
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center